Acumen Pharmaceuticals reported total assets of $116.01M and total liabilities of $58.74M for the quarter ended Jun 2026, down 32.5% year over year. This balance sheet covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables - AccuredAcc. Int. Receivables | 0.23M | 0.05M | |||||||||||||||||||||||
| Assets | |||||||||||||||||||||||||
| Current Assets | |||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 135.80M | 122.16M | 108.76M | 111.07M | 157.54M | 130.10M | 78.00M | 77.25M | 94.92M | 66.89M | 46.93M | 67.95M | 33.18M | 35.63M | 30.16M | 36.81M | 46.83M | 53.99M | 51.80M | 59.44M | |||||
| Receivables - OtherOther Receivables | 0.11M | 0.23M | 0.19M | 0.11M | 0.27M | 0.34M | 0.38M | 0.32M | 0.38M | 0.62M | 0.77M | 1.00M | |||||||||||||
| Prepaid Assets | 4.84M | 4.42M | 3.01M | 1.14M | 2.37M | 2.72M | 3.62M | 4.66M | 3.16M | 3.82M | 3.32M | 6.44M | 7.29M | 7.24M | 6.30M | 5.50M | 5.94M | 5.74M | 5.00M | 5.58M | |||||
| Current Assets | 204.91M | 198.66M | 192.10M | 191.05M | 202.56M | 180.33M | 144.03M | 149.54M | 218.60M | 246.62M | 255.83M | 266.92M | 207.63M | 178.31M | 154.95M | 148.40M | 132.15M | 122.25M | 133.09M | 115.51M | |||||
| Non-Current Assets | |||||||||||||||||||||||||
| Property, Plant & Equipment (Net) | 0.01M | 0.04M | 0.05M | 0.11M | 0.14M | 0.17M | 0.15M | 0.14M | 0.12M | 0.12M | 0.12M | 0.10M | 0.09M | ||||||||||||
| Long-Term Investments | 29.91M | 31.62M | 27.66M | 20.00M | 15.84M | 43.42M | 27.31M | 67.27M | 62.55M | 44.11M | 20.91M | 58.55M | 59.97M | 48.80M | 22.80M | 9.44M | |||||||||
| Other Non-Current Assets | 0.01M | 0.01M | 0.08M | 0.11M | 0.15M | 0.20M | 0.21M | 0.19M | 0.72M | 0.32M | 0.42M | 0.24M | 0.49M | 0.50M | 0.46M | 0.39M | 0.35M | 0.30M | 0.26M | ||||||
| Non-Current Assets | 29.94M | 31.67M | 27.99M | 20.62M | 0.70M | 16.26M | 43.83M | 27.87M | 67.77M | 63.51M | 45.14M | 22.00M | 59.34M | 60.69M | 49.53M | 23.49M | 10.07M | 0.58M | 0.54M | 0.49M | |||||
| Assets | 234.85M | 230.33M | 220.09M | 211.68M | 203.26M | 196.59M | 187.86M | 177.41M | 286.37M | 310.12M | 300.97M | 288.91M | 266.98M | 238.99M | 204.48M | 171.90M | 142.22M | 122.83M | 133.63M | 116.01M | |||||
| Liabilities | |||||||||||||||||||||||||
| Current Liabilities | |||||||||||||||||||||||||
| Accounts Payables | 0.38M | 1.09M | 1.22M | 1.71M | 2.08M | 1.64M | 0.76M | 2.03M | 1.36M | 1.38M | 3.08M | 4.21M | 2.34M | 5.65M | 1.06M | 2.10M | 0.68M | 0.55M | 1.66M | 13.38M | |||||
| Notes Payables | 3.60M | 8.77M | 14.12M | 19.67M | |||||||||||||||||||||
| Payables | 0.38M | 1.09M | 1.22M | 1.71M | 2.08M | 1.64M | 0.76M | 2.03M | 1.36M | 1.38M | 3.08M | 4.21M | 2.34M | 5.65M | 1.06M | 2.10M | 4.28M | 9.32M | 15.78M | 33.05M | |||||
| Accumulated Expenses | 1.11M | 3.91M | 2.58M | 3.28M | 4.40M | 3.35M | 2.75M | 2.37M | 3.17M | 6.45M | 2.90M | 4.00M | 4.93M | 6.62M | 6.71M | 11.65M | 7.79M | 10.07M | 5.27M | 7.53M | |||||
| Other Accumulated Expenses | 0.12M | 0.20M | 0.10M | 0.10M | 0.04M | ||||||||||||||||||||
| Short term Debt | 3.60M | 8.77M | 14.12M | 19.67M | |||||||||||||||||||||
| Current Leases | 0.14M | 0.14M | 0.13M | 0.10M | 0.07M | 0.03M | 0.00M | 0.76M | 0.12M | 0.12M | 0.13M | ||||||||||||||
| Total Current Liabilities | 5.15M | 3.94M | 5.13M | 6.61M | 7.81M | 8.78M | 8.53M | 6.10M | 12.97M | 8.47M | 15.37M | 19.91M | 27.61M | 19.32M | 24.86M | 21.96M | 30.01M | 29.23M | 46.85M | ||||||
| Non-Current Liabilities | |||||||||||||||||||||||||
| Non-Current Debt | 29.90M | 30.21M | 29.38M | 29.67M | 29.42M | 29.53M | 29.88M | 27.05M | 22.40M | 16.92M | 11.90M | ||||||||||||||
| Non-Current Deffered Revenue | 0.24M | 0.34M | 0.18M | ||||||||||||||||||||||
| Preferred Stock Liabilities | |||||||||||||||||||||||||
| Operating Leases | 0.20M | 0.17M | 0.13M | 0.28M | 0.25M | 0.22M | 0.18M | ||||||||||||||||||
| Other Non-Current Liabilities | 0.28M | 0.15M | 0.11M | 0.08M | 0.04M | ||||||||||||||||||||
| Total Non-Current Liabilities | 42.87M | 57.03M | 48.84M | 54.74M | 49.01M | 52.40M | |||||||||||||||||||
| Total Liabilities | 1.49M | 5.15M | 4.00M | 5.16M | 6.61M | 7.81M | 8.78M | 8.53M | 6.10M | 43.15M | 38.93M | 44.97M | 49.77M | 57.18M | 48.96M | 54.82M | 49.05M | 52.40M | 46.15M | 58.74M | |||||
| Shareholder's Equity | |||||||||||||||||||||||||
| Total Debt | 29.90M | 30.21M | 29.38M | 29.67M | 29.42M | 29.53M | 29.88M | 34.25M | 39.93M | 45.17M | 51.24M | ||||||||||||||
| Common Equity | 233.36M | 225.18M | 216.09M | 206.52M | 196.65M | 188.78M | 179.09M | 168.87M | 280.27M | 266.97M | 262.03M | 243.95M | 217.20M | 181.82M | 155.52M | 117.08M | 93.17M | 70.43M | 87.48M | 57.26M | |||||
| Liabilities and Shareholders Equity | 234.85M | 230.33M | 220.09M | 211.68M | 203.26M | 196.59M | 187.86M | 177.41M | 286.37M | 310.12M | 300.97M | 288.91M | 266.98M | 238.99M | 204.48M | 171.90M | 142.22M | 122.83M | 133.63M | 116.01M | |||||
| Retained Earnings | 352.61M | 352.98M | 353.60M | 354.33M | 355.17M | 359.95M | 361.34M | 362.86M | 487.08M | 489.45M | 499.84M | 502.31M | 504.65M | 506.99M | 509.42M | 511.92M | 514.38M | 516.80M | 554.65M | 557.19M | |||||
| Treasury Shares |